Stockscreener 앱 받기
30.97
0.93%
-0.29
시간 외 거래:
31.05
0.08
+0.26%
전일 마감가:
$31.26
열려 있는:
$31.525
하루 거래량:
5.75M
Relative Volume:
0.55
시가총액:
$11.98B
수익:
$3.14B
순이익/손실:
$-3.36B
주가수익비율:
-3.5475
EPS:
-8.73
순현금흐름:
$-4.03B
1주 성능:
-5.78%
1개월 성능:
+19.58%
6개월 성능:
-13.71%
1년 성능:
-74.43%
1일 변동 폭
$30.88
$32.07
1주일 범위
$30.88
$33.31
52주 변동 폭
$23.15
$125.68
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
MRNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
30.97 | 12.71B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
New York State Common Retirement Fund Sells 33,365 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
What drives Moderna Inc. stock pricePowerful growth strategies - Autocar Professional
Lexicography: Clear And Unequivocal - The National Law Review
Wealthfront Advisers LLC Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo - BioSpace
What analysts say about Moderna Inc. stockFree Investment Timing Strategies - jammulinksnews.com
Moderna Bets Big On New Vaccines After Stock Tumbles - Finimize
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by South Dakota Investment Council - MarketBeat
Is Moderna Inc. a good long term investmentRobust investment performance - jammulinksnews.com
Moderna Inc. Stock Analysis and ForecastMarket-beating returns - Jammu Links News
Edgestream Partners L.P. Has $2.78 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Buys 17,268 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Nisa Investment Advisors LLC - MarketBeat
Moderna, Inc. (MRNA) Aktienkurs, Nachrichten, Kurs und Verlauf - yahoo.co
Here's Why Moderna (MRNA) Fell More Than Broader Market - Yahoo Finance
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance
How IBM and Moderna’s partnership could lead to an explosion in drug development - Fast Company
Investors Buy Large Volume of Call Options on Moderna (NASDAQ:MRNA) - MarketBeat
Moderna cancels plans to build Japan plant on poor business environment - Reuters
Moderna gets full FDA approval for kids COVID-19 vaccine - MSN
Moderna, Inc.'s (NASDAQ:MRNA) Price Is Right But Growth Is Lacking After Shares Rocket 26% - simplywall.st
Moderna cancels mRNA production plant in Japan (MRNA:NASDAQ) - Seeking Alpha
Cwm LLC Purchases 28,831 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Lobbying Update: $120,000 of MODERNA INC. lobbying was just disclosed - Quiver Quantitative
How IBM and Moderna (MRNA) Are Using Quantum Computing to Design Vaccines Faster - TipRanks
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Amarillo Globe-News
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease - Knoxville News Sentinel
IBM-Moderna Showcase Quantum-Enhanced Drug Discovery - HPCwire
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. - Barron's
Director, Strategic Forecasting, Oncology job with Moderna, Inc. | 1402245670 - New Scientist
Moderna’s latest approval again reveals FDA rift over COVID vaccines - BioPharma Dive
William Blair Issues Negative Outlook for Moderna Earnings - MarketBeat
Bank of New York Mellon Corp Purchases 34,034 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children - Vaccine Advisor
Lobbying Update: $100,000 of MODERNA US INC. lobbying was just disclosed - Quiver Quantitative
Moderna patent for mRNA vaccine knocked back, for now - Lawyerly
Moderna: Ready For The Redemption Arc (NASDAQ:MRNA) - Seeking Alpha
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA) - Yahoo Finance
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - Yahoo Finance
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - The Motley Fool
What to Expect From Moderna's Next Quarterly Earnings Report - MSN
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):